Novelion Therapeutics Inc., of Vancouver, British Columbia, said Aegerion Pharmaceuticals, an indirect, wholly owned subsidiary, entered into an agreement in principle to settle all claims in the class action shareholder lawsuit pending in the U.S. District Court for the District of Massachusetts.